AT-56Notwithstanding a variety of setbacks, quite a few MDM2 inhibitors have now progressed into late-stage medical growth. New procedures have also been created to enhance the efficacy of MDM2 inhibitors and also to mitigate their on-target toxicity. In this evaluation, we summarize the progress and problems in the development of a MDM2 targeted t… Read More